Siderophore Competition

Siderophore Piracy (Xenosiderophore Use)#

Many bacteria possess receptors for siderophores they do not produce, allowing them to steal iron from competitors. Salmonella can use enterobactin produced by commensal E. coli, gaining iron without the metabolic cost of siderophore synthesis. Some organisms produce siderophore-degrading enzymes that release iron from competitors' chelates.

The Lipocalin-2 Checkpoint#

The host immune system actively participates in siderophore warfare through lipocalin-2 (Lcn2), an innate immune protein that.

Binds and neutralizes enterobactin, the most common Gram-negative siderophore. Creates a selective pressure favoring pathogens with stealth siderophores (salmochelin, yersiniabactin, aerobactin) that evade Lcn2. This means that host Nutritional Immunity (Metal Sequestration) inadvertently selects for more virulent siderophore-producing strains.^{[1]Bushman 2025 — The Exploitation of Nutrient Metals by Bacteria for Survival and Infection in the GutSummer D Bushman, Eric P Skaar, N Luisa Hiller · 2025Open reference 1 ↓}

Commensal Iron Ecology#

Beneficial gut bacteria have their own iron strategies.

Lactobacillus species have minimal iron requirements, giving them a competitive advantage in iron-restricted environments—they don't need siderophores at all. Bifidobacterium species use ferric iron reductases rather than siderophores for iron acquisition. The loss of these iron-frugal commensals in Dysbiosis shifts the competitive landscape toward siderophore-dependent pathogens.

Siderophores as Antimicrobial Tools#

The high iron affinity of siderophores has inspired antimicrobial strategies.

Pyoverdine-based iron deprivation: Screening of 320 natural pyoverdine variants identified structures that potently inhibit Acinetobacter baumannii, Klebsiella pneumoniae, and Staphylococcus aureus by competitive iron starvation. The iron-dependent mechanism shows low host toxicity and reduced resistance evolution compared to conventional antibiotics.^{[2]Vollenweider et al. 2024 — Pyoverdines as Iron-Depriving AntimicrobialsVollenweider, V., et al. · 2024Open reference 2 ↓}

Siderophore-antibiotic conjugates (Trojan horse strategy): Antibiotics linked to siderophores are actively imported by bacterial iron uptake systems, concentrating the drug inside the target cell. Cefiderocol (approved 2019) uses this mechanism against multidrug-resistant Gram-negatives.

Metal chelation therapy: Synthetic chelators that mimic siderophore iron binding can starve pathogens, with demonstrated activity against Pseudomonas and Acinetobacter.^{[3]Golden et al. 2024 — Metal Chelation as Antibacterial Strategy Against Pseudomonas and AcinetobacterGolden, M., et al. · 2024Open reference 3 ↓}

Clinical Relevance#

Siderophore competition matters for disease because it determines who wins the iron war in the inflamed gut. In Crohn's Disease, Adherent-Invasive Escherichia coli (AIEC) AIEC strains carry multiple siderophore systems (enterobactin + salmochelin + yersiniabactin), giving them a decisive advantage over commensals.

Oral iron supplementation floods the gut with available iron, paradoxically favoring siderophore-producing pathogens over iron-frugal commensals—a key reasoning behind Nutritional Immunity (Metal Sequestration)-informed intervention design.

Understanding siderophore ecology informs the design of ecological interventions that restrict pathogen iron access rather than killing bacteria directly.